Praxis Precision Medicines, Inc.
PRAX • NASDAQ • Stock Fundamentals
Praxis Precision Medicines, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Marcio Silva De'Souza, with a market cap of $6.9B.
Market Cap$6.9B
Employees82.0
CEOMarcio Silva De'Souza
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 3, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Praxis Precision Medicines, Inc. FAQ
Common questions about Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. (PRAX) has a market capitalization of $6.9B and trades on NASDAQ.
Praxis Precision Medicines, Inc. has approximately 82 employees.